Interstitial Pregnancy Treated with Mifepristone and Methotrexate with High Serum β-hCG Level in a Patient Wishing to Preserve Fertility: Time to Define Standardized Criteria for Medical/Surgical Therapy?
- PMID: 36141736
- PMCID: PMC9516977
- DOI: 10.3390/ijerph191811464
Interstitial Pregnancy Treated with Mifepristone and Methotrexate with High Serum β-hCG Level in a Patient Wishing to Preserve Fertility: Time to Define Standardized Criteria for Medical/Surgical Therapy?
Abstract
Interstitial pregnancy (IP) accounts for 2% of all ectopic pregnancies and has a mortality rate of 2-2.5%. The diagnosis is made by a transvaginal ultrasound and the treatment can be medical or surgical. We report the case of a 36-year-old primigravida who was 6 + 5 weeks pregnant, diagnosed with interstitial pregnancy by ultrasound, who had a very high serum β-hCG level (31,298 mIU/mL) and wanted to preserve her fertility. The patient was treated with one dose of mifepristone and a double dose of methotrexate since the decrease in the β-hCG serum level was less than 15% after the first dose. At the beginning, medical therapy was effective, as no embryonal cardiac activity was detected and serum β-hCG levels decreased early, but on the 20th day of hospitalization, the patient underwent surgery for her clinical symptoms and the evidence of free fluid in the Douglas pouch at a transvaginal ultrasound exam. Our experience showed that medical treatment should be considered, especially in women wishing to preserve their fertility. Further studies are needed to establish a standardized protocol and maybe a clinical score that can be useful in predicting the patients in which medical therapy could be most successful.
Keywords: cornuostomy; interstitial pregnancy; medical treatment; methotrexate; mifepristone; non-tubal ectopic pregnancy (EPs); β-hCG.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Conservative Treatment of Interstitial Ectopic Pregnancy with the Combination of Mifepristone and Methotrexate: Our Experience and Review of the Literature.Biomed Res Int. 2020 Aug 1;2020:8703496. doi: 10.1155/2020/8703496. eCollection 2020. Biomed Res Int. 2020. PMID: 32802882 Free PMC article. Review.
-
Surgical Treatment Following Failed Medical Treatment of an Interstitial Pregnancy.Medicina (Kaunas). 2022 Jul 15;58(7):937. doi: 10.3390/medicina58070937. Medicina (Kaunas). 2022. PMID: 35888656 Free PMC article.
-
Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment.Int J Environ Res Public Health. 2021 Sep 17;18(18):9781. doi: 10.3390/ijerph18189781. Int J Environ Res Public Health. 2021. PMID: 34574706 Free PMC article. Review.
-
Conservative management of interstitial pregnancies: experience of a single centre.J Obstet Gynaecol. 2018 Aug;38(6):848-853. doi: 10.1080/01443615.2017.1417979. Epub 2018 Mar 14. J Obstet Gynaecol. 2018. PMID: 29537335
-
Interstitial ectopic pregnancy successfully treated with methotrexate.BMJ Case Rep. 2023 Apr 26;16(4):e252588. doi: 10.1136/bcr-2022-252588. BMJ Case Rep. 2023. PMID: 37185311 Free PMC article.
Cited by
-
The relationship between serum levels of epidermal growth factor and β-human chorionic gonadotropin and the type and prognosis of ectopic pregnancy.Arch Gynecol Obstet. 2024 Aug;310(2):1179-1187. doi: 10.1007/s00404-024-07523-0. Epub 2024 Apr 29. Arch Gynecol Obstet. 2024. PMID: 38683393
-
The Use of Methotrexate and Mifepristone for Treatment of Interstitial Pregnancies: An Overview of Effectiveness and Complications.J Clin Med. 2023 Nov 29;12(23):7396. doi: 10.3390/jcm12237396. J Clin Med. 2023. PMID: 38068448 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources